Laryngeal carcinoma in nonsmoking patients

被引:8
作者
Hamzany, Yaniv [1 ]
Hadar, Tuvia
Feinmesser, Raphael
Guttman, Dan
Shvero, Jacob
机构
[1] Rabin Med Ctr, Dept Otolaryngol Head & Neck Surg, IL-49100 Petah Tiqwa, Israel
关键词
laryngeal carcinoma; nonsmoker; past smoker; survival;
D O I
10.1177/000348940811700802
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objectives: Smoking is a known risk factor for laryngeal carcinoma. We sought to describe the clinicopathologic characteristics and outcomes of nonsmoking patients with laryngeal carcinoma. Methods: Of 1,443 patients treated for laryngeal carcinoma between 1960 and 2006, 55 (3.8%) were nonsmokers: 40 (73%) had never smoked and 15 (27%) had stopped smoking 12 years or more before diagnosis. Patient characteristics and outcomes were reviewed. Results: The study group consisted of 87% men; the mean age at diagnosis was 67 years. All lesions but one were located in the glottis. The 5-year survival rate for the whole group was 85%. Most tumors were detected early. Of 38 patients (69%) with stage T1 disease, there was no significant difference in prognostic features between those who had never smoked and those who had smoked in the past. Conclusions: Fewer than 5% of patients with laryngeal carcinoma were nonsmokers. Like smokers, this subgroup was characterized by a male predominance and an approximate age at diagnosis in the seventh decade. Unlike smokers, nonsmokers show a greater predilection for glottic rather than supraglottic disease. There was no difference in prognosis between smokers and nonsmokers, regardless of whether they had smoked in the past.
引用
收藏
页码:564 / 568
页数:5
相关论文
共 42 条
[1]  
Agudelo D, 1997, HEAD NECK-J SCI SPEC, V19, P200, DOI 10.1002/(SICI)1097-0347(199705)19:3<200::AID-HED6>3.0.CO
[2]  
2-6
[3]   Cessation of smoking and drinking and the risk of laryngeal cancer [J].
Altieri, A ;
Bosetti, C ;
Talamini, R ;
Gallus, S ;
Franceschi, S ;
Levi, F ;
Dal Maso, L ;
Negri, E ;
La Vecchia, C .
BRITISH JOURNAL OF CANCER, 2002, 87 (11) :1227-1229
[4]  
Biacabe B, 1998, HEAD NECK-J SCI SPEC, V20, P510, DOI 10.1002/(SICI)1097-0347(199809)20:6<510::AID-HED4>3.0.CO
[5]  
2-0
[6]  
BRENDEL MD, 2001, INT ISLET TRANSPLANT, V8, P4
[7]  
BURCH JD, 1981, J NATL CANCER I, V67, P1219
[8]   Supraglottic and glottic carcinomas: Epidemiologically distinct entities? [J].
De Stefani, E ;
Boffetta, P ;
Deneo-Pellegrini, H ;
Brennan, P ;
Correa, P ;
Oreggia, F ;
Ronco, AL ;
Mendilaharsu, M .
INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (06) :1065-1071
[9]  
FALK RT, 1989, CANCER RES, V49, P4024
[10]   EARLY-STAGE SQUAMOUS-CELL CARCINOMA OF THE GLOTTIC LARYNX MANAGED WITH RADIATION-THERAPY [J].
FOOTE, RL ;
OLSEN, KD ;
KUNSELMAN, SJ ;
SCHAID, DJ ;
BUSKIRK, SJ ;
GRADO, GL ;
EARLE, JD .
MAYO CLINIC PROCEEDINGS, 1992, 67 (07) :629-636